2026 NPPES data Hematology & Oncology Physician NPI 1053471318 M.D.
Verify on CMS →

DIVYA KOURA, M.D.

Hematology & Oncology Physician in LA JOLLA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
735
Medicare Part D claims · 57 beneficiaries · Hematology & Oncology Physician avg: 847

What the federal data shows

DIVYA KOURA, M.D. filed 735 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in LA JOLLA, California.

735
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

DIVYA KOURA, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

735 Top 29% higher than 71% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

DIVYA KOURA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about DIVYA KOURA, M.D.?

Quality data not reported

NPI registry status

Active

Issued 12/09/2006

NPI 1053471318

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

735 13% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in California

How Hematology & Oncology Physician compares to other specialties among California providers

California providers

Hematology & Oncology Physician share within California

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DIVYA KOURA, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 10710 N TORREY PINES RD, LA JOLLA, CA, 92037, with a listed phone of (858) 554-8788. NPI 1053471318 was issued on 12/09/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KOURA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 735 prescription claims written by this provider, covering 57 Medicare beneficiaries and totaling roughly $2.2 million in drug spend, with an opioid prescribing rate of 2.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

10710 N TORREY PINES RD
LA JOLLA, CA 92037

Provider Details

NPI 1053471318
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 12/09/2006

Hospital and facility affiliations

Facilities where DIVYA KOURA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SCRIPPS HEALTH
LA JOLLA, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to DIVYA KOURA, M.D.. To verify DIVYA KOURA, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

735
Total Claims
$2.2M
Total Drug Cost
57
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
887
Total Day Supply
23,552
Generic Drug Cost
$176K
Opioid Claims
18 (2.4% rate)
Antibiotic Claims
75

Patient Demographics

Average Patient Age
66.8 years
Avg HCC Risk Score
3.29
Gender Split
42% female / 58% male
Age Distribution
<65: 13, 65-74: 31, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What DIVYA KOURA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Acyclovir
96
Famotidine
35
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
35
Iclusig
Ponatinib Hcl
34
Revlimid
Lenalidomide
30
Atovaquone
29
Eliquis
Apixaban
28
Prednisone
24
Gabapentin
22
Ondansetron Odt
Ondansetron
18

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How DIVYA KOURA, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

DIVYA KOURA, M.D.'s 735 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as KOURA.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DIVYA KOURA, M.D.'s specialty?
DIVYA KOURA, M.D. specializes in Hematology & Oncology Physician and practices in LA JOLLA, California. Credentials: M.D..
How much does DIVYA KOURA, M.D. prescribe under Medicare Part D?
In 2023, DIVYA KOURA, M.D. wrote 735 Medicare Part D claims totaling $2.2M in drug costs for 57 beneficiaries.
Where is DIVYA KOURA, M.D. located?
DIVYA KOURA, M.D. is located at 10710 N TORREY PINES RD, LA JOLLA, CA, 92037. Phone: (858) 554-8788.
What is DIVYA KOURA, M.D.'s NPI number?
DIVYA KOURA, M.D.'s National Provider Identifier (NPI) is 1053471318, issued on 12/09/2006.
Does DIVYA KOURA, M.D. prescribe opioids?
Yes, DIVYA KOURA, M.D. had 18 opioid claims in 2023 with an opioid prescribing rate of 2.4%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does DIVYA KOURA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, DIVYA KOURA, M.D.'s most frequently prescribed drugs include Acyclovir, Famotidine, Sulfamethoxazole-Trimethoprim. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DIVYA KOURA, M.D. accept Medicare?
DIVYA KOURA, M.D. appears in CMS Medicare data with 735 Part D claims and 57 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DIVYA KOURA, M.D.'s credentials?
DIVYA KOURA, M.D.'s NPI is 1053471318 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology